Beta Bionics, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Beta Bionics, Inc.
- Regulatory records
- 4
- Linked recall entries
- 3
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 4 FDA records to the applicant name Beta Bionics, Inc.. The collection includes 4 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Apr 30, 2026 to Oct 21, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QFG appears in 3 of the 4 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 11 Hughes, Irvine, CA, 92618, US. Recorded on K263422, decision dated Oct 21, 2026.
Device categories in this collection
Alternate Controller Enabled Insulin Infusion Pump; Interoperable Automated Glycemic Controller.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 3 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 3 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
iLet Bionic Pancreas, REF: BB1001Z-2513-2026 | Beta Bionics, Inc. | Class II | Jun 24, 2026 | FDA |
iLet Bionic Pancreas, REF: BB1001Z-1996-2026 | Beta Bionics, Inc. | Class II | May 6, 2026 | FDA |
| Beta Bionics, Inc. | Class II | Apr 22, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Source updated Nov 11, 2026. Retrieved Nov 20, 2026.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Mint ACE PumpK263422 | Beta Bionics, Inc. | 510(k) clearance | Oct 21, 2026 | FDA |
Mint ACE PumpK260001 | Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA |
| Beta Bionics, Inc. | 510(k) clearance | Sep 11, 2026 | FDA | |
iLet ACE PumpK253976 | Beta Bionics, Inc. | 510(k) clearance | Apr 30, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.




